← Leaderboards
Stefano Guerra
University Of Arizona
$15,496,395
Attributed
$25,997,659
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,997,659 · 7
By mechanism
R01$24,368,903 · 4
P50$905,863 · 1
R21$722,893 · 2
Top collaborators
- Fernando D Martinez13 shared
- Anne L. Wright8 shared
Most similar at University Of Arizona
Same institution · by research overlap
- Fernando D Martinez$68,375,515
- Robert Clark Lantz$7,364,102
- David M. Almeida$9,170,572
- Marykay O'Rourke$617,059
- Martha S Hunter$1,226,308
Others in their field
Top investigators on “Cohort”
- David R. Weir · University Of Michigan At Ann Arbor$406,814,098
- George R Seage · Abt Associates, Inc.$297,656,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
CohortChronicAsthmaRespiratoryLinkMorbidity - Disease RateSerumAdultParticipantChronic Obstructive Airway DiseaseChildhoodLungLifeChildMolecularBirthEpidemiologyProspectiveRespiratory PhysiologySmokerMortalitySamplingPathway InteractionsAirway Inflammation
Grant awards (33)
Early Origins of Chronic Lung Disease: From Birth to Age 45 Years$1,774,009
R01 · FY2025 · HL
CC16 in childhood and resilience to early airflow limitation in adult life$772,287
R01 · FY2025 · AI · contact PI
Creatine Kinase in the Natural History of Asthma$193,646
R21 · FY2025 · AI · contact PI
Creatine Kinase in the Natural History of Asthma$231,626
R21 · FY2024 · AI · contact PI
Early Origins of Chronic Lung Disease: Outcomes into the Fifth Decade of Life$1,519,797
R01 · FY2023 · HL
Early Origins of Chronic Lung Disease: Outcomes into the Fifth Decade of Life$1,517,972
R01 · FY2022 · HL
Early Origins of Chronic Lung Disease: Outcomes into the Fifth Decade of Life$1,473,403
R01 · FY2021 · HL
CC16 in Childhood and Resilience to Persistent Asthma into Adult Life$723,046
R01 · FY2021 · AI · contact PI
Early Origins of Chronic Lung Disease: Outcomes into the Fifth Decade of Life$1,519,158
R01 · FY2020 · HL
CC16 in Childhood and Resilience to Persistent Asthma into Adult Life$734,189
R01 · FY2020 · AI · contact PI
CC16 in Childhood and Resilience to Persistent Asthma into Adult Life (Supplement)$149,165
R01 · FY2020 · AI · contact PI
CC16 in Childhood and Resilience to Persistent Asthma into Adult Life$89,002
R01 · FY2020 · AI · contact PI
Early Origins of Chronic Airflow Limitation: Outcomes Into the 4th Decade of Life$1,376,435
R01 · FY2019 · HL
CC16 in Childhood and Resilience to Persistent Asthma into Adult Life$739,101
R01 · FY2019 · AI · contact PI
Early Origins of Chronic Airflow Limitation: Outcomes Into the 4th Decade of Life$1,376,435
R01 · FY2018 · HL
CC16 in Childhood and Resilience to Persistent Asthma into Adult Life$688,549
R01 · FY2018 · AI · contact PI
Early Origins of Chronic Airflow Limitation: Outcomes Into the 4th Decade of Life$1,376,435
R01 · FY2017 · HL
CC16 in Childhood and Resilience to Persistent Asthma into Adult Life$727,579
R01 · FY2017 · AI · contact PI
Early Origins of Chronic Airflow Limitation: Outcomes Into the 4th Decade of Life$1,408,546
R01 · FY2016 · HL
Childhood Predictors of Airway Structure, Function, and Disease in Adult Life$1,102,034
R01 · FY2015 · HL
Childhood Predictors of Airway Structure, Function, and Disease in Adult Life$1,096,440
R01 · FY2014 · HL
Childhood Predictors of Airway Structure, Function, and Disease in Adult Life$1,053,881
R01 · FY2013 · HL
Serum Biomarkers of COPD: a population-based prospective study$356,964
R01 · FY2013 · HL · contact PI
Childhood Predictors of Airway Structure, Function, and Disease in Adult Life$1,108,436
R01 · FY2012 · HL
Validation of serum biomarker signatures predictive of incident COPD$448,813
P50 · FY2012 · HL · contact PI
Serum Biomarkers of COPD: a population-based prospective study$374,963
R01 · FY2012 · HL · contact PI
Validation of serum biomarker signatures predictive of incident COPD$457,050
P50 · FY2011 · HL · contact PI
Serum Biomarkers of COPD: a population-based prospective study$378,750
R01 · FY2011 · HL · contact PI
Serum Biomarkers of COPD: a population-based prospective study$378,229
R01 · FY2010 · HL · contact PI
Serum Biomarkers of COPD: a population-based prospective study$377,500
R01 · FY2009 · HL · contact PI
Serum Biomarkers of COPD: a population-based prospective study$176,598
R01 · FY2009 · HL · contact PI
Serum Inflammatory Biomarkers as Predictors of COPD Morbidity and Morality$146,621
R21 · FY2007 · HL · contact PI
Serum Inflammatory Biomarkers as Predictors of COPD Morbidity and Morality$151,000
R21 · FY2006 · HL · contact PI